January 2002

|
Volume 2 Issue 1

Editorial Staff

Clinical Editor
Bradley Knight, MD
Executive Editor
Laurie Gustafson
Managing Editor
Jodie Elrod
Production Manager
Alexa Flinn

Editorial Correspondence

Jodie Elrod, Managing Editor, EP Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (800) 371-0791

Fax: (866) 488-8273
Email: jelrod@hmpglobal.com
Syncope: Neurologic or Neurocardiogenic?
Syncope is a very common problem, accounting for approximately 1-3% of all emergency room visits and up to 6% of hospital admissions. Often, extensive and expensive neurological work-ups are done prior to any cardiac work-up. Surprisingly, neurolog…
Interview with Todd J. Cohen, MD
What is currently happening in the field of electrophysiology and what are the problems? TC: Electrophysiology is the most rapidly growing field in cardiology. It is a very exciting time to be in electrophysiology. In particular, we are seeing an ex…
SASEAP Workshop: Myrtle Beach 2001
The Friday session was devoted to the novice EP allied professional. Speakers discussed issues that included radiation safety, follow-up of the CHF patient, interpretation of difficult pacing strips, 12-Lead ECGs, syncope, pharmacology and basic EP s…
"The Evolution of Pacemaker Follow-Up" with Dr. Michael Bergelson
Paceart has been a pioneer in the concept and application of computerized pacemaker follow-up, both for clinical and transtelephonic monitoring. They are the established market leader with over 900 pacemaker and arrhythmia centers utilizing its syste…
Advanced Mapping
for Advanced Cures
In the recent past, before 1985 and the FDA approval of the Automatic Implantable Cardioverter-Defibrillator (ICD), the primary treatment for life-threatening ventricular tachycardia was drug therapy.1 Unfortunately, many of the antiarrhythmic drugs…
Big News for Implantable Defibrillators: Indications Expanding
The principal investigator of this trial was Arthur J. Moss, MD, from the University of Rochester Medical Center, Rochester, New York (also the principal investigator of MADIT I). The study, which was sponsored by Guidant Corporation in St. Paul, Min…
Spotlight Interview
EMH Regional Healthcare System
EMH Regional Healthcare System (formerly Elyria Memorial Hospital), which was founded in 1915, is a 438-bed, two-hospital system with campuses in Elyria and Amherst, Ohio. We have a full array of immediate diagnostic and therapeutic cardiac services,…
A Primer on Antiarrhythmic Drug Action
The use of drugs to favorably alter heart rhythm began in 1914 with quinidine, whose antiarrhythmic actions were found by accident. Since that time, the number and complexity of drug categories has evolved to the extent that we have come closer to un…